Ane Gerda Zahl Eriksson, Head of the endometrial cancer and gynecologic sarcoma team at the Radium Hospital, shared a post by Sara Hassing Johansen,Researcher at Universitetet i Oslo, adding:
“Grateful to be part of this outstanding group of researchers bringing an interventional study on exercise to Endometrial Cancer survivors.
SENSOR-LIIFE is an exciting continuation of on our work in the SENSOR study exploring outcomes after the implementation of sentinel lymph node biopsy in women with endometrial cancer.
This is a rare opportunity for this patient population.
Thank you Tormod Nilsen for persevering with this project and embracing our patients. Thank you Sara Hassing Johansen for taking on this challenge. Thank you Kreftforeningen for seeing the importance of supporting our research.”
Quoting Sara Hassing Johansen‘s post:
“Maybe my new favorite video!
One of the greatest ambitions for an early-career researcher is to secure external funding. The Norwegian Cancer Society’s main research call is highly competitive and prestigious, with a very narrow acceptance rate. Thanks to an outstanding research team led by Dr. Tormod Nilsen, this dream has now become a reality.
A sincere thanks to the Norwegian Cancer Society for awarding nearly NOK 6.5 million to our new project investigating the effects of exercise in women treated for endometrial cancer. A big thank-you as well to the rest of the project group, which brings together exceptional researchers and experts from the Norwegian School of Sport Sciences, Oslo University Hospital, and University of Oslo.
This funding not only allows us to continue our work, but also brings us closer to closing critical knowledge gaps- and ensuring that more people who have undergone cancer treatment can benefit from exercise.
SENSOR-LIIFE study- hard to believe you’re happening. See you soon.”
More from Ane Gerda Zahl Eriksson on OncoDaily.